Literature DB >> 14329092

THE USE OF ALLOPURINOL (HPP) TO CONTROL HYPERURICEMIA IN PATIENTS ON CHRONIC INTERMITTENT HEMODIALYSIS.

C P HAYES, E N METZ, R R ROBINSON, R W RUNDLES.   

Abstract

Entities:  

Keywords:  BLOOD; CREATINE AND CREATININE; DRUG THERAPY; GLOMERULONEPHRITIS; HYPERTENSION, MALIGNANT; KIDNEY, ARTIFICIAL; PYRIMIDINES; URIC ACID; URICOSURIC AGENTS

Mesh：

Substances：

Year:  1965        PMID： 14329092     DOI： 10.1097/00002480-196504000-00047

Source DB:  PubMed          Journal:  Trans Am Soc Artif Intern Organs        ISSN： 0066-0078


× No keyword cloud information.
  4 in total

Review 1.  Managing Gout in the Patient with Renal Impairment.

Authors:  Eliseo Pascual; Francisca Sivera; Mariano Andrés
Journal:  Drugs Aging       Date:  2018-04       Impact factor: 3.923

2.  Use and abuse of allopurinol.

Authors:  J S Cameron; H A Simmonds
Journal:  Br Med J (Clin Res Ed)       Date:  1987-06-13

3.  Management of Gout and Hyperuricemia in CKD.

Authors:  Ana Beatriz Vargas-Santos; Tuhina Neogi
Journal:  Am J Kidney Dis       Date:  2017-04-26       Impact factor: 8.860

4.  Successful use of allopurinol in a patient on dialysis.

Authors:  Richard Osborne Day; Diluk Romesh Wijekoon Kannangara; James M Hayes; Timothy J Furlong
Journal:  BMJ Case Rep       Date:  2012-06-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.